Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder

JAMA Psychiatry

Volumn 70, Issue 3, 2013, Pages 291-299

  Croarkin, Paul E ^a   Nakonezny, Paul A ^b   Husain, Mustafa M ^c   Melton, Tabatha ^c   Buyukdura, Jeylan S ^c   Kennard, Betsy D ^c   Emslie, Graham J ^c   Kozel, F Andrew ^d   Daskalakis, Zafiris J ^e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID;

ADOLESCENT; ARTICLE; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPH; EVOKED MUSCLE RESPONSE; EXCITABILITY; FACILITATION; FAMILY HISTORY; FEMALE; GABAERGIC SYSTEM; HUMAN; MAJOR DEPRESSION; MALE; NERVE STIMULATION; NEUROTRANSMISSION; SCHOOL CHILD; STIMULUS RESPONSE;

EID: 84874900646     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamapsychiatry.24     Document Type: Article

References (69)

1. Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC, Kawakami N, Kiliç C, Offord D, Ustun TB, Wittchen HU. The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys [published correction appears in Int J Methods Psychiatr Res. 2003;12(3):165]. Int J Methods Psychiatr Res. 2003;12(1):3-21. (Pubitemid 36675444)
2. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. (Pubitemid 37432885)
3. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747-1757. (Pubitemid 43767064)
4. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
5. Zalsman G, Oquendo MA, Greenhill L, Goldberg PH, Kamali M, Martin A, Mann JJ. Neurobiology of depression in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2006;15(4):843-868, vii-viii. (Pubitemid 44307692)
6. Kennard BD, Silva SG, Tonev S, Rohde P, Hughes JL, Vitiello B, Kratochvil CJ, Curry JF, Emslie GJ, Reinecke M, March J. Remission and recovery in the Treatment for Adolescents With Depression Study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry. 2009;48(2):186-195.
7. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-339. (Pubitemid 43345358)
8. Liberzon I, George SA. SSRI-enhanced locus coeruleus activity and adolescent suicide: lessons from animal models. Neuropsychopharmacology. 2010;35 (8):1619-1620.
9. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7(2):137-151. (Pubitemid 43151600)
10. Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci. 2003;1003:250-272. (Pubitemid 38083061)
11. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63-77.
12. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002;7(suppl 1):S71-S80. (Pubitemid 34280651)
13. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262(5134):689-695. (Pubitemid 23350687)
14. Takao M, Morigiwa K, Sasaki H, Miyoshi T, Shima T, Nakanishi S, Nagai K, Fukuda Y. Impaired behavioral suppression by light in metabotropic glutamate receptor subtype 6-deficient mice. Neuroscience. 2000;97(4):779-787. (Pubitemid 30332186)
15. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 1994;13(5):1031-1037. (Pubitemid 24372123)
16. Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426-437. (Pubitemid 351619114)
17. Frye MA, Tsai GE, Huggins T, Coyle JT, Post RM. Low cerebrospinal fluid glutamate and glycine in refractory affective disorder [published correction appears in Biol Psychiatry. 2007;61(10):1221].
18. Biol Psychiatry. 2007;61(2):162-166.
19. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63(4):349-352. (Pubitemid 351146651)
20. Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58(9):700-704. (Pubitemid 41547237)
21. Moore CM, Frazier JA, Glod CA, Breeze JL, Dieterich M, Finn CT, Frederick B, Renshaw PF. Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am Acad Child Adolesc Psychiatry. 2007;46(4): 524-534. (Pubitemid 46622762)
22. Benes FM. Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity. Biol Psychiatry. 1995;38(12):783-787.
23. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry. 2003;160(3):577-579. (Pubitemid 41094271)
24. Sanacora G, Mason GF, Krystal JH. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol. 2000; 14(1):23-45. (Pubitemid 32193048)
25. Petty F, Kramer GL, Fulton M, Davis L, Rush AJ. Stability of plasma GABA at fouryear follow-up in patients with primary unipolar depression. Biol Psychiatry. 1995; 37(11):806-810.
26. Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC. Anterior cingulate cortex -aminobutyric acid in depressed adolescents: relationship to anhedonia. Arch Gen Psychiatry. 2012;69(2):139-149.
27. Prosser J, Hughes CW, Sheikha S, Kowatch RA, Kramer GL, Rosenbarger N, Trent J, Petty F. Plasma GABA in children and adolescents with mood, behavior, and comorbid mood and behavior disorders: a preliminary study. J Child Adolesc Psychopharmacol. 1997;7(3):181-199. (Pubitemid 28062577)
28. McClintock SM, Freitas C, Oberman L, Lisanby SH, Pascual-Leone A. Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia. Biol Psychiatry. 2011;70(1):19-27.
29. Ngomo S, Leonard G, Moffet H, Mercier C. Comparison of transcranial magnetic stimulation measures obtained at rest and under active conditions and their reliability. J Neurosci Methods. 2012;205(1):65-71.
30. Ziemann U, Steinhoff BJ, Tergau F, Paulus W. Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res. 1998;30(1):11-30. (Pubitemid 28141122)
31. Stagg CJ, Bestmann S, Constantinescu AO, Moreno LM, Allman C, Mekle R, Woolrich M, Near J, Johansen-Berg H, Rothwell JC. Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J Physiol. 2011;589(pt 23):5845-5855.
32. Dolberg OT, Dannon PN, Schreiber S, Grunhaus L. Magnetic motor threshold and response to TMS in major depressive disorder. Acta Psychiatr Scand. 2002; 106(3):220-223.
33. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol. 1996;40(3):367-378. (Pubitemid 26304794)
34. Trevillion L, Howells J, Bostock H, Burke D. Properties of low-threshold motor axons in the human median nerve. J Physiol. 2010;588(pt 13):2503-2515.
35. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Pilato F, Zito G, Dileone M, Nicoletti R, Pasqualetti P, Tonali PA. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol. 2003;547(pt 2):485- 496. (Pubitemid 36304982)
36. Ziemann U, Chen R, Cohen LG, Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology. 1998;51(5):1320-1324. (Pubitemid 28520551)
37. Richter MA, de Jesus DR, Hoppenbrouwers S, Daigle M, Deluce J, Ravindran LN, Fitzgerald PB, Daskalakis ZJ. Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder. Neuropsychopharmacology. 2012; 37(5):1144-1151.
38. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501-519. (Pubitemid 23345592)
39. Ziemann U, Rothwell JC, Ridding MC. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol. 1996;496(pt 3):873- 881. (Pubitemid 26387868)
40. Connors BW, Malenka RC, Silva LR. Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses in neocortex of rat and cat. J Physiol. 1988;406:443-468.
41. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry. 2002;59(4):347-354. (Pubitemid 34275253)
42. Ziemann U. TMS and drugs. Clin Neurophysiol. 2004;115(8):1717-1729. (Pubitemid 38952939)
43. Bajbouj M, Lang UE, Neu P, Heuser I. Therapeutic brain stimulation and cortical excitability in depressed patients. Am J Psychiatry. 2005;162(11):2192-2193. (Pubitemid 41598284)
44. Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P. Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry. 2006;59(5):395-400. (Pubitemid 43289217)
45. Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry. 2010;67(5):458-464.
46. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children- Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988. (Pubitemid 27272932)
47. Poznanski EO, Mokros HB. Children's Depression Rating Scale, Revised (CDRS-R). Los Angeles, CA: Western Psychological Services; 1996.
48. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression (Pubitemid 37289445)
49. [published correction appears in Biol Psychiatry. 2003;54(5):585].
50. Biol Psychiatry. 2003;54(5):573-583.
51. Keel JC, Smith MJ,Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol. 2001;112(4):720. (Pubitemid 32245647)
52. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97-113.
53. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995; 57(1):289-300.
54. Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47(4):305-313. (Pubitemid 30109243)
55. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, Fiebich M, Arolt V, Heindel W. Effective electroconvulsive therapy reverses glutamate/ glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 2003;122(3):185-192. (Pubitemid 36412193)
56. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurringwith electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med. 2003; 33(7):1277-1284. (Pubitemid 37265215)
57. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64(2):193-200. (Pubitemid 46220776)
58. Mall V, Berweck S, Fietzek UM, Glocker FX, Oberhuber U, Walther M, Schessl J, Schulte-Mönting J, Korinthenberg R, Heinen F. Low level of intracortical inhibition in children shown by transcranial magnetic stimulation. Neuropediatrics. 2004; 35(2):120-125. (Pubitemid 38639319)
59. Garvey MA, Ziemann U, Bartko JJ, Denckla MB, Barker CA, Wassermann EM. Cortical correlates of neuromotor development in healthy children. Clin Neurophysiol. 2003;114(9):1662-1670. (Pubitemid 37025799)
60. Fulton MK, Armitage R, Rush AJ. Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression: a pilot study. Biol Psychiatry. 2000;47(7):618-625. (Pubitemid 30169255)
61. Armitage R, Emslie GJ, Hoffmann RF, Weinberg WA, Kowatch RA, Rintelmann J, Rush AJ. Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents. Biol Psychiatry. 2000;47(4):338-350. (Pubitemid 30109247)
62. Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int. 2007; 51(6-7):333-355. (Pubitemid 47503456)
63. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164(3880):719-721.
64. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science. 1969;166(3903):386-388.
65. Walther M, Berweck S, Schessl J, Linder-Lucht M, Fietzek UM, Glocker FX, Heinen F, Mall V. Maturation of inhibitory and excitatory motor cortex pathways in children. Brain Dev. 2009;31(7):562-567.
66. Ryan ND, Puig-Antich J, Ambrosini P, Rabinovich H, Robinson D, Nelson B, Iyengar S, Twomey J. The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry. 1987;44(10):854-861. (Pubitemid 17155442)
67. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM. Abnormal luteal phase excitability of the motor cortex in womenwith premenstrual syndrome. Biol Psychiatry. 2003;54(7):757-762. (Pubitemid 37281393)
68. Wassermann EM. Variation in the response to transcranial magnetic brain stimulation in the general population. Clin Neurophysiol. 2002;113(7):1165-1171. (Pubitemid 34667156)
69. Farzan F, Barr MS, Levinson AJ, Chen R, Wong W, Fitzgerald PB, Daskalakis ZJ. Reliability of long-interval cortical inhibition in healthy human subjects: a TMSEEG study. J Neurophysiol. 2010;104(3):1339-1346.